 |
|
Successful switching from insulin to sulfonylurea in a 3-month-old infant with diabetes due to p.G53D mutation in KCNJ11
Jong Seo Yoon, Kyu Jung Park, Young Bae Sohn, Hae Sang Lee, Jin Soon Hwang
Ann Pediatr Endocrinol Metab. 2018;23(3):154-157. Published online 2018 Sep 28 DOI: https://doi.org/10.6065/apem.2018.23.3.154
|
|
Citations to this article as recorded by
 Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants
Valentina Mancioppi, Erica Pozzi, Sara Zanetta, Anna Missineo, Silvia Savastio, Fabrizio Barbetti, Simona Mellone, Mara Giordano, Ivana Rabbone
Frontiers in Endocrinology.2023;[Epub] CrossRef Epidemiology and phenotypes of diabetes in children and adolescents in non-European-origin populations in or from Western Pacific region
Steven James, Jayanthi Maniam, Pik-To Cheung, Tatsuhiko Urakami, Julia von Oettingen, Supawadee Likitmaskul, Graham Ogle
World Journal of Clinical Pediatrics.2022; 11(2): 173. CrossRef Neonatal Diabetes Mellitus Due to KCNJ11 (KIR6.2) Mutation Successfully Treated with Sulfonylurea
Sehun Jang, Misun Yang, So Yoon Ahn, Se In Sung, Yun Sil Chang, Won Soon Park
Neonatal Medicine.2021; 28(2): 94. CrossRef Genes predisposing to neonatal diabetes mellitus and pathophysiology: Current findings
T.O. Yahaya, D.A. Anyebe
Journal of Neonatal-Perinatal Medicine.2020; 13(4): 543. CrossRef
|